Jennifer E. Cook, Director at Denali Therapeutics Inc. (DNLI), sold 1,458 shares at $21.73 ($32K) on 2024-06-06, disclosed to the SEC on 2024-06-10.
Scheduled sale ($32k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BBIO | SELL | 2026-06-17 | $6.0M | — | Filing → |
| JAZZ | SELL | 2023-12-06 | $50K | — | Filing → |
| JAZZ | SELL | 2023-08-15 | $343K | — | Filing → |